/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Sylvie Chabaud

Université Claude Bernard Lyon 1(FR)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

364

Papers

10.3K

Citations

46

h-index

135

i10-index

Sylvie Chabaud is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Sarcoma Diagnosis and Treatment & Cancer Immunotherapy and Biomarkers & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 46, co-authored 310 publications.

ORCID: 0000-0003-4655-6867

Research Topics

Sarcoma Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Gastrointestinal Tumor Research and Treatment Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics

Papers by this author

works

Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial

2020 · The Lancet Oncology · 307 citations

https://doi.org/10.1016/s1470-2045(20)30454-x

Paul Sargos Sylvie Chabaud I. Latorzeff Nicolas Magné

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients

2018 · European Journal of Cancer · 65 citations

https://doi.org/10.1016/j.ejca.2018.03.013

Emmanuelle Jacquet Audrey Lardy-Cléaud Barbara Pistilli Sophie Franck

Validation of prognostic scores for survival in cancer patients beyond first-line therapy

2011 · BMC Cancer · 44 citations

https://doi.org/10.1186/1471-2407-11-95

Olivier Trédan Isabelle Ray‐Coquard Gisèle Chvetzoff Paul Rebattu

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer

2021 · ESMO Open · 30 citations

https://doi.org/10.1016/j.esmoop.2020.100044

Pierre-Étienne Heudel Sylvie Chabaud David Pérol Aude Fléchon

Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Primary Breast Cancer

2022 · Journal of Clinical Oncology · 29 citations

https://doi.org/10.1200/jco.21.02179

Thomas Bachelot Paul Cottu Sylvie Chabaud Florence Dalenc

A methodological framework for drug development in rare diseases

2014 · Orphanet Journal of Rare Diseases · 26 citations

https://doi.org/10.1186/s13023-014-0164-y

Patrice Nony Polina Kurbatova Agathe Bajard Salma Malik

Research topics

topics

Sarcoma Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Gastrointestinal Tumor Research and Treatment

Lung Cancer Treatments and Mutations

Cancer Genomics and Diagnostics

Chat about Author

Papers

Chat

Click to start Chat